Mucpharm
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Pitney Bldg, L3 Short St, Kogarah, New S...Phone Number
+61 291132070Website
www.mucpharm.comRevenue
<$5 MillionIndustry
About Mucpharm
Mucpharm is a specialized company dedicated to developing treatments for mucin-containing and secreting conditions, particularly focusing on advanced cancers such as pseudomyxoma peritonei. Their lead compound, BromAc, is being investigated in clinical trials for its efficacy in oncology and respiratory diseases, aiming to improve treatment outcomes by sensitizing cancer cells to chemotherapy. The company is recognized for its internationally esteemed research team and is committed to addressing unmet medical needs through innovative therapies. Mucpharm seeks to expand its scientific and clinical research efforts in Australia while fostering global partnerships.Explore more
SIC Code 28,283NAICS Code 32,325Show more
Mucpharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mucpharm
Compare insights from companies similar to Mucpharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mucpharm Tech Stack
A closer look at the technologies used by Mucpharm
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mucpharm
Sign Up For FreeTo access detailed company insights
Mucpharm is a specialized company dedicated to developing treatments for mucin-containing and secreting conditions, particularly focusing on advanced cancers such as pseudomyxoma peritonei. Their lead compound, BromAc, is being investigated in clinical trials for its efficacy in oncology and respiratory diseases, aiming to improve treatment outcome... Read More
